Ftse Mib
34.492,41
0,13%
DAX
18.497,94
-0,09%
S&P 500
5.277,51
0,80%
NASDAQ
16.735,02
-0,01%
Bitcoin
67.626,99
-0,15%
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Vascular Biogenics Ltd (VBLT) Vascular Biogenics Ltd (VBLT) Notizie

VBLT

Vascular Biogenics (VBLT)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:VBLT
DataOraFonteTitoloSimboloCompagnia
10/05/202423:18Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VBLTVascular Biogenics Ltd
06/05/202422:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VBLTVascular Biogenics Ltd
19/04/202422:56Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:VBLTVascular Biogenics Ltd
11/04/202423:00Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:VBLTVascular Biogenics Ltd
01/04/202422:30Edgar (US Regulatory)Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405NASDAQ:VBLTVascular Biogenics Ltd
16/02/202415:00Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:VBLTVascular Biogenics Ltd
05/02/202423:00Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:VBLTVascular Biogenics Ltd
11/01/202423:22Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:VBLTVascular Biogenics Ltd
08/01/202422:21Edgar (US Regulatory)Form RW - Registration Withdrawal RequestNASDAQ:VBLTVascular Biogenics Ltd
29/11/202323:15Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:VBLTVascular Biogenics Ltd
26/10/202323:15Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:VBLTVascular Biogenics Ltd
26/10/202323:15Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:VBLTVascular Biogenics Ltd
19/10/202319:34Edgar (US Regulatory)Form SC 13D - General statement of acquisition of beneficial ownershipNASDAQ:VBLTVascular Biogenics Ltd
17/10/202323:01Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:VBLTVascular Biogenics Ltd
10/10/202314:01Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:VBLTVascular Biogenics Ltd
02/10/202323:29Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:VBLTVascular Biogenics Ltd
06/09/202306:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:VBLTVascular Biogenics Ltd
05/09/202321:52Edgar (US Regulatory)Form S-4/A - Registration of securities, business combinations: [Amend]NASDAQ:VBLTVascular Biogenics Ltd
14/08/202314:10Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:VBLTVascular Biogenics Ltd
09/06/202322:32Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:VBLTVascular Biogenics Ltd
15/05/202322:46Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:VBLTVascular Biogenics Ltd
15/05/202322:11Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:VBLTVascular Biogenics Ltd
18/04/202322:37Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VBLTVascular Biogenics Ltd
14/03/202313:02Edgar (US Regulatory)Annual Report (10-k)NASDAQ:VBLTVascular Biogenics Ltd
09/12/202223:15Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:VBLTVascular Biogenics Ltd
18/11/202212:15TipRanksH.C. Wainwright Reaffirms Their Hold Rating on Vascular Biogenics (VBLT)NASDAQ:VBLTVascular Biogenics Ltd
20/07/202214:55TipRanksVascular Biogenics (VBLT) Receives a Hold from JonesTradingNASDAQ:VBLTVascular Biogenics Ltd
20/07/202212:15TipRanksAnalysts Offer Insights on Healthcare Companies: Celsion (CLSN), Vascular Biogenics (VBLT) and Portage Biotech Inc (PRTG)NASDAQ:VBLTVascular Biogenics Ltd
20/05/202219:25TipRanksJonesTrading Remains a Buy on Vascular Biogenics (VBLT)NASDAQ:VBLTVascular Biogenics Ltd
18/05/202212:17TipRanksH.C. Wainwright Sticks to Their Buy Rating for Vascular Biogenics (VBLT)NASDAQ:VBLTVascular Biogenics Ltd
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:VBLT

La tua Cronologia

USOTC
OTMES
Otis Collection (PK)
AMEX
CGM
Congoleum
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network